Efficacy and Safety of Pegzilarginase in Patients With Arginase 1 Deficiency
Clinical trial NCT03921541 · COMPLETED
Trial details
- NCT number
- NCT03921541
- Sponsor
- Immedica Pharma AB
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2023-02-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.